BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30348286)

  • 1. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.
    Gribouval O; Boyer O; Hummel A; Dantal J; Martinez F; Sberro-Soussan R; Etienne I; Chauveau D; Delahousse M; Lionet A; Allard J; Pouteil Noble C; Tête MJ; Heidet L; Antignac C; Servais A
    Kidney Int; 2018 Nov; 94(5):1013-1022. PubMed ID: 30348286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
    Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
    Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
    Bullich G; Trujillano D; Santín S; Ossowski S; Mendizábal S; Fraga G; Madrid Á; Ariceta G; Ballarín J; Torra R; Estivill X; Ars E
    Eur J Hum Genet; 2015 Sep; 23(9):1192-9. PubMed ID: 25407002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
    Vivante A; Chacham OS; Shril S; Schreiber R; Mane SM; Pode-Shakked B; Soliman NA; Koneth I; Schiffer M; Anikster Y; Hildebrandt F
    Pediatr Nephrol; 2019 Sep; 34(9):1607-1613. PubMed ID: 31001663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
    Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
    Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
    Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis.
    Gast C; Pengelly RJ; Lyon M; Bunyan DJ; Seaby EG; Graham N; Venkat-Raman G; Ennis S
    Nephrol Dial Transplant; 2016 Jun; 31(6):961-70. PubMed ID: 26346198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.
    Santín S; Bullich G; Tazón-Vega B; García-Maset R; Giménez I; Silva I; Ruíz P; Ballarín J; Torra R; Ars E
    Clin J Am Soc Nephrol; 2011 May; 6(5):1139-48. PubMed ID: 21415313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.
    Sharif B; Barua M
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):194-200. PubMed ID: 29465426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
    Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
    Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children.
    Maruyama K; Iijima K; Ikeda M; Kitamura A; Tsukaguchi H; Yoshiya K; Hoshii S; Wada N; Uemura O; Satomura K; Honda M; Yoshikawa N
    Pediatr Nephrol; 2003 May; 18(5):412-6. PubMed ID: 12687458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syndrome.
    Benoit G; Machuca E; Nevo F; Gribouval O; Lepage D; Antignac C
    Pediatr Nephrol; 2010 Mar; 25(3):445-51. PubMed ID: 19956976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
    Lovric S; Ashraf S; Tan W; Hildebrandt F
    Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children.
    Frishberg Y; Rinat C; Megged O; Shapira E; Feinstein S; Raas-Rothschild A
    J Am Soc Nephrol; 2002 Feb; 13(2):400-405. PubMed ID: 11805168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
    Preston R; Stuart HM; Lennon R
    Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of nephrotic syndrome--review.
    Obeidová H; Merta M; Reiterová J; Maixnerová D; Stekrová J; Rysavá R; Tesar V
    Prague Med Rep; 2006; 107(1):5-16. PubMed ID: 16752799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
    Gigante M; Caridi G; Montemurno E; Soccio M; d'Apolito M; Cerullo G; Aucella F; Schirinzi A; Emma F; Massella L; Messina G; De Palo T; Ranieri E; Ghiggeri GM; Gesualdo L
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1626-34. PubMed ID: 21734084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.